Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overview of hormonal therapy in advanced breast cancer.
Schacter LP, Rozencweig M, Canetta R, Kelley S, Nicaise C, Smaldone L. Schacter LP, et al. Among authors: canetta r. Semin Oncol. 1990 Dec;17(6 Suppl 9):38-46. Semin Oncol. 1990. PMID: 2148026
Megestrol acetate: clinical experience.
Schacter L, Rozencweig M, Canetta R, Kelley S, Nicaise C, Smaldone L. Schacter L, et al. Among authors: canetta r. Cancer Treat Rev. 1989 Mar;16(1):49-63. doi: 10.1016/0305-7372(89)90004-2. Cancer Treat Rev. 1989. PMID: 2471590 Review.
Drug discovery and development in the pharmaceutical industry.
Schacter LP, Anderson C, Canetta RM, Kelley S, Nicaise C, Onetto N, Rozencweig M, Smaldone L, Winograd B. Schacter LP, et al. Among authors: canetta rm. Semin Oncol. 1992 Dec;19(6):613-21. Semin Oncol. 1992. PMID: 1462163 Review.
Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patients.
Rozencweig M, McLaren C, Beltangady M, Ritter J, Canetta R, Schacter L, Kelley S, Nicaise C, Smaldone L, Dunkle L, et al. Rozencweig M, et al. Among authors: canetta r. Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S570-5. doi: 10.1093/clinids/12.supplement_5.s570. Rev Infect Dis. 1990. PMID: 2166965 Clinical Trial.
Carboplatin: current status and future prospects.
Canetta R, Bragman K, Smaldone L, Rozencweig M. Canetta R, et al. Cancer Treat Rev. 1988 Jun;15 Suppl B:17-32. doi: 10.1016/0305-7372(88)90031-x. Cancer Treat Rev. 1988. PMID: 2841021 Review. No abstract available.
Clinical status of carboplatin.
Canetta R, Franks C, Smaldone L, Bragman K, Rozencweig M. Canetta R, et al. Oncology (Williston Park). 1987 Jul;1(5):61-70. Oncology (Williston Park). 1987. PMID: 3079484 Review.
Overview of Taxol safety.
Onetto N, Canetta R, Winograd B, Catane R, Dougan M, Grechko J, Burroughs J, Rozencweig M. Onetto N, et al. Among authors: canetta r. J Natl Cancer Inst Monogr. 1993;(15):131-9. J Natl Cancer Inst Monogr. 1993. PMID: 7912519 Review.
Carboplatin: the clinical spectrum to date.
Canetta R, Rozencweig M, Carter SK. Canetta R, et al. Cancer Treat Rev. 1985 Sep;12 Suppl A:125-36. doi: 10.1016/0305-7372(85)90027-1. Cancer Treat Rev. 1985. PMID: 3002623 Review.
57 results